Yingzhe Wang (Lindsey Wang)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 9

Top Topics

Top Venues

Nature communications

Molecular cancer therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Noha A M Shendy, Melissa Bikowitz, Logan H Sigua, Yang Zhang, Audrey Mercier, Yousef Khashana, Stephanie Nance, Qi Liu, Ian M Delahunty, Sarah Robinson, Vanshita Goel, Matthew G Rees, Melissa A Ronan, Tingjian Wang, Mustafa Kocak, Jennifer A Roth, Yingzhe Wang, Burgess B Freeman, Brent A Orr, Brian J Abraham, Martine F Roussel, Ernst K Schonbrunn, Jun Qi, Adam D Durbin
Group 3 medulloblastoma transcriptional networks collapse under domain specific EP300/CBP inhibition. Nature communications 15 (1) (2024)
Noha A M Shendy, Melissa Bikowitz, Logan H Sigua, Yang Zhang, Audrey Mercier, Yousef Khashana, Stephanie Nance, Qi Liu, Ian M Delahunty, Sarah Robinson, Vanshita Goel, Matthew G Rees, Melissa A Ronan, Tingjian Wang, Mustafa Kocak, Jennifer A Roth, Yingzhe Wang, Burgess B Freeman, Brent A Orr, Brian J Abraham, Martine F Roussel, Ernst K Schonbrunn, Jun Qi, Adam D Durbin
Group 3 medulloblastoma transcriptional networks collapse under domain specific EP300/CBP inhibition. Nature communications 15 (1) (2024)
Noha A M Shendy, Melissa Bikowitz, Logan H Sigua, Yang Zhang, Audrey Mercier, Yousef Khashana, Stephanie Nance, Qi Liu, Ian M Delahunty, Sarah Robinson, Vanshita Goel, Matthew G Rees, Melissa A Ronan, Tingjian Wang, Mustafa Kocak, Jennifer A Roth, Yingzhe Wang, Burgess B Freeman, Brent A Orr, Brian J Abraham, Martine F Roussel, Ernst K Schonbrunn, Jun Qi, Adam D Durbin
Group 3 medulloblastoma transcriptional networks collapse under domain specific EP300/CBP inhibition. Nature communications 15 (1) (2024)
Noha A M Shendy, Melissa Bikowitz, Logan H Sigua, Yang Zhang, Audrey Mercier, Yousef Khashana, Stephanie Nance, Qi Liu, Ian M Delahunty, Sarah Robinson, Vanshita Goel, Matthew G Rees, Melissa A Ronan, Tingjian Wang, Mustafa Kocak, Jennifer A Roth, Yingzhe Wang, Burgess B Freeman, Brent A Orr, Brian J Abraham, Martine F Roussel, Ernst K Schonbrunn, Jun Qi, Adam D Durbin
Group 3 medulloblastoma transcriptional networks collapse under domain specific EP300/CBP inhibition. Nature communications 15 (1) (2024)
Noha A M Shendy, Melissa Bikowitz, Logan H Sigua, Yang Zhang, Audrey Mercier, Yousef Khashana, Stephanie Nance, Qi Liu, Ian M Delahunty, Sarah Robinson, Vanshita Goel, Matthew G Rees, Melissa A Ronan, Tingjian Wang, Mustafa Kocak, Jennifer A Roth, Yingzhe Wang, Burgess B Freeman, Brent A Orr, Brian J Abraham, Martine F Roussel, Ernst K Schonbrunn, Jun Qi, Adam D Durbin
Group 3 medulloblastoma transcriptional networks collapse under domain specific EP300/CBP inhibition. Nature communications 15 (1) (2024)
Rebekah Honce, Jeremy Jones, Victoria A Meliopoulos, Brandi Livingston, Bridgett Sharp, Leonardo D Estrada, Yingzhe Wang, William Caulfield, Burgess Freeman, Elena A Govorkova, Stacey Schultz-Cherry
Efficacy of oseltamivir treatment in influenza virus-infected obese mice. mBio (2023)
Martine F Roussel, Barbara Jonchere, Justin S Williams, Frederique Zindy, JingJing Liu, Sarah Robinson, Dana M Farmer, Jaeki Min, Lei Yang, Jennifer L Stripay, Yingzhe Wang, Burgess B Freeman, Jiyang Yu, Anang A Shelat, Zoran Rankovic
Combination of ribociclib with BET-bromodomain and PI3K/mTOR inhibitors for medulloblastoma treatment in vitro and in vivo. Molecular cancer therapeutics (2022)
Min Pan, William C Wright, Richard H Chapple, Asif Zubair, Manbir Sandhu, Jake E Batchelder, Brandt C Huddle, Jonathan Low, Kaley B Blankenship, Yingzhe Wang, Brittney Gordon, Payton Archer, Samuel L Brady, Sivaraman Natarajan, Matthew J Posgai, John Schuetz, Darcie Miller, Ravi C Kalathur, Siquan Chen, Jon Patrick Connelly, M Madan Babu, Michael A Dyer, Shondra M Pruett-Miller, Burgess B Freeman, Taosheng Chen, Lucy A Godley, Scott C Blanchard, Elizabeth A Stewart, John Easton, Paul Geeleher
The chemotherapeutic CX-5461 primarily targets TOP2B and exhibits selective activity in high-risk neuroblastoma. Nature communications 12 (1) (2021)
Chen He, Ke Xu, Xiaoyan Zhu, Paige S Dunphy, Brian Gudenas, Wenwei Lin, Nathaniel Twarog, Laura D Hover, Chang-Hyuk Kwon, Lawryn H Kasper, Junyuan Zhang, Xiaoyu Li, James Dalton, Barbara Jonchere, Kimberly S Mercer, Duane G Currier, William V Caufield, Yingzhe Wang, Jia Xie, Alberto Broniscer, Cynthia Wetmore, Santhosh A Upadhyaya, Ibrahim Qaddoumi, Paul Klimo, Frederick Boop, Amar Gajjar, Jinghui Zhang, Brent A Orr, Giles W Robinson, Michelle Monje, Burgess B Freeman Iii, Martine F Roussel, Paul A Northcott, Taosheng Chen, Zoran Rankovic, Gang Wu, Jason Chiang, Christopher L Tinkle, Anang A Shelat, Suzanne J Baker
Patient-derived models recapitulate heterogeneity of molecular signatures and drug response in pediatric high-grade glioma. Nature communications 12 (1) (2021)